Context Therapeutics Inc.
CNTX
Last
$0.30
Day
+1.7%
1y
-78.6%
5y
-94.1%
52w
-91.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0425d
EMA 21
0.34
EMA 50
0.47
EMA 200
1.11
20d high
-25.3%
5y high
-97.2%
5y range
0th
Positions held
Your positionsCNTX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$0.35
Stop
$0.26
Stop distance
14.5%
Target vs last
+15.1%
Fundamentals
| Market cap | $27.47M | Enterprise value | -$15.27M | Trailing P/E | — | Forward P/E | -0.69 |
| PEG | — | Price / book | 0.72 | Beta | 1.72 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -76.1% | ROA | -45.7% | Debt / equity | 0.01 |
| Current ratio | 5.81 | Free cash flow | -$31.53M | Analyst recommendation | none | Mean target | $4.03 |
| 52w high | $3.62 | 52w low | $0.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$14.6M | -$8.7M | -$13.0M | -$9.7M | -$8.8M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$15.0M | -$9.3M | -$13.8M | -$10.6M | -$9.8M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$36.1M | -$26.7M | -$24.0M | -$14.8M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$39.7M | -$29.9M | -$25.1M | -$14.9M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsCNTX · daily-23.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin